CVRx (CVRX) Other Non-Current Liabilities (2020 - 2026)
CVRx's (CVRX) quarterly Other Non-Current Liabilities came in at $2.1 million in Q1 2026, up 32.26% year-on-year from $1.6 million in Q1 2025, and up 4.9% quarter-over-quarter from $2.0 million in Q4 2025.
CVRx (CVRX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
CVRx's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 32.26% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 32.26% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 38.29% from the prior year.
- Other Non-Current Liabilities rose to $2.1 million in Q1 2026 per CVRX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.1 million in Q1 2026 and bottomed at $706000.0 in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $1.2 million (2024), against an average of $1.2 million.
- Across the five-year window, Other Non-Current Liabilities declined 19.13% in 2022 and surged 43.54% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $805000.0 in 2022, then advanced by 28.7% to $1.0 million in 2023, then jumped by 39.67% to $1.4 million in 2024, then surged by 38.29% to $2.0 million in 2025, then grew by 4.9% to $2.1 million in 2026.
- Per Business Quant, the three latest CVRX Other Non-Current Liabilities figures stand at $2.1 million (Q1 2026), $2.0 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.10 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 960,000.00 |
| Jun 30, 2023 | 885,000.00 |
| Mar 31, 2023 | 815,000.00 |
| Dec 31, 2022 | 805,000.00 |
| Sep 30, 2022 | 761,000.00 |
| Jun 30, 2022 | 732,000.00 |
| Mar 31, 2022 | 706,000.00 |
| Dec 31, 2021 | 681,000.00 |
| Sep 30, 2021 | 941,000.00 |
| Jun 30, 2021 | 884,000.00 |